The skin, genital system, and hematological involvement of diffuse large B-cell lymphomas are quite rare. Diagnosis and disease classification are based on histological review and immunohistochemical staining. PCDLBCL is an aggressive lymphoma with an inferior prognosis. However, timely recognition can have important clinical and therapeutic implications.